Thromb Haemost 1987; 58(02): 772-777
DOI: 10.1055/s-0038-1645968
Original Article
Schattauer GmbH Stuttgart

The Isolation and Characterization of a Ternary Human Plasmin B-Chain-Streptokinase-Plasminogen Complex

Louis Summaria
1   The Section of Hemostasis and Thrombosis, Department of Surgery, Evanston Hospital, Evanston, lllinois
,
Irena Boreisha
2   The Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois
,
Grant H Barlow
3   The Bioprocessing Research Center, Houston, Texas, USA
,
Kenneth C Robbins
2   The Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 27. November 1986

Accepted after revision 28. April 1987

Publikationsdatum:
27. Juni 2018 (online)

Summary

A ternary equimolar human plasmin B-chain-streptokinase-plasminogen complex was isolated from a mixture of the plasmin B-chain-streptokinase complex and human plasminogen at 0° C and 37° C. A ternary complex which was shown to be species specific, was identified and characterized by ultracentrifugal, acrylamide gel electrophoretic, and agarose double diffusion analyses. When mixed at a 1:1 molar ratio at 0° C, 39.9% of the preparation existed as a plasmin B-chain-streptokinase-plasmino-gen complex; when mixed at 37° C, 86.d% existed as a complex, which was identified by electrophoretic analyses to be a plasmin B-chain-streptokinase-plasmin complex. Sedimentation velocity analyses gave s°2o,w values of 3.79 for the plasmin B-chain-streptokinase complex, 4.10 for Lys-plasmin, and 6.23 for the plasmin B-chain-streptokinase-plasmin complex. Sedimentation equilibrium analyses gave molecular weights of 73,900 for the plasmin B-chain-streptokinase complex, 82,900 for Lys-plasmin, and 153,100 for the plasmin B-chain-streptokinase-plasmin complex. The diisopropylphosphorofluoridatc (DFP)-inhibitcd and the p-nitrophenyl-p-guanidino-benzoate (NPGB)-inhibited plasmin B-chain-streptokinase complexes both retained their ability to form a ternary complex with human plasminogen, but this complex did not convert to a plasmin B-chain-streptokinase-plasmin complex. Thus, the active site serine residue is essential for the activator activity of the plasmin B-chain-streptokinase complex, but it is not necessary for the binding of the plasmin B-chain-streptokinase complex to plasminogen to form a ternary complex.

 
  • References

  • 1 Davies MC, Englert ME, DeRenzo EC. Interaction of streptokinase and human plasminogen. I. Combination of streptokinase and plasminogen observed in the ultracentrifuge under a variety of experimental conditions. J Biol Chem 1964; 239: 2651-2658
  • 2 Markus G, Werkheiser WC. The interaction of streptokinase and plasminogen. I. Functional properties of the activated enzyme. J Biol Chem 1964; 239: 2637-2643
  • 3 Buck FF, Hummel BCW, DeRenzo EC. Interaction of streptokinase and human plasminogen. V. Studies on the nature and mechanism of formation of the enzymatic site of the activator complex. J Biol Chem 1968; 243: 3648-3654
  • 4 Summaria L, Ling CM, Groskopf WR, Robbins KC. The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin. J Biol Chem 1968; 243: 144-150
  • 5 McClintock DK, Bell PH. Mechanism of activation of human plasminogen by streptokinase. Biochem Biophys Res Commun 1971; 43: 694-702
  • 6 Reddy K NN, Markus G. Mechanism of activation of human plasminogen by streptokinase: presence of an active center in streptokinase-plasminogen complex. J Biol Chem 1972; 247: 1683-1691
  • 7 Schick LA, Castellino FJ. Interaction of streptokinase and rabbit plasminogen. Biochemistry 1973; 12: 4315-4321
  • 8 Summaria L, Wohl RC, Boreisha IG, Robbins KC. A virgin enzyme derived from human plasminogen. Specific cleavage of the Arg560-Val peptide bond in the DIP-virgin enzyme by plasminogen activators. Biochemistry 1982; 21: 2056-2059
  • 9 Wohl RC, Summaria L, Arzadon L, Robbins KC. Steady-state kinetics of activation of human and bovine plasminogen by streptokinase and its equimolar complexes with various activated forms of human plasminogen. J Biol Chem 1978; 253: 1402-1407
  • 10 Summaria L, Robbins KC. Isolation of a human plasmin-derived functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity. J Biol Chem 1976; 251: 5810-5813
  • 11 Wohl RC, Summaria L, Robbins KC. Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. J Biol Chem 1979; 254: 9063-9069
  • 12 Wohl RC, Summaria L, Robbins KC. Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37° C. J Biol Chem 1980; 255: 2005-2013
  • 13 Robbins KC, Summaria L. Plasminogen and plasmin. Methods Enzymol 1976; 45 (22) 257-273
  • 14 Robbins KC, Summaria L, Elwyn D, Barlow GH. Further studies on the purification and characterization of human plasminogen and plasmin. J Biol Chem 1965; 240: 541-550
  • 15 Gaffney PJ, Mussett MV. International collaborative study for the establishment of the second international reference preparation of plasmin. Thromb Haemostas 1983; 50: 645-649
  • 16 Robbins KC, Summaria L, Hsieh B, Shah R. The peptide chains of human plasmin. J Biol Chem 1967; 242: 2333-2342
  • 17 Sottrup-Jensen L, Claeys H, Zajdel M, Peterson TE, Magnusson S. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Rowan RM, Samama MM, Desnoyers PC. (eds.) Vol. 3 pp. 191-209 Raven Press; New York: 1978
  • 18 Summaria L, Arzadon L, Bernabe P, Robbins KC. Isolation, characterization, and comparison of the Cm-heavy (A) and Cm-light (B) chain derivatives of cat, dog, rabbit, and bovine plasmins. J Biol Chem 1973; 248: 6522-6527
  • 19 Summaria L, Arzadon L, Bernabe P, Robbins KC. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods. J Biol Chem 1972; 247: 4691-4702
  • 20 Summaria L, Arzadon L, Bernabe P, Robbins KC. The activation of plasminogen to plasmin by urokinase in the presence of the plasmin inhibitor trasylol: The absence of peptide bond cleavage at the amino-terminal end of zymogen. J Biol Chem 1975; 250: 3988-3995
  • 21 Taylor Jr FB, Botts C. Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. J Biochemistry 1968; 7: 232-237
  • 22 Cohn EJ, McMeekin TL, Edsall JT, Blanchard MH. Studies in the physical chemistry of aminoacids, peptides and related substances. I. The apparent molal volume and the electrostriction of the solvent. J Amer Chem Soc 1934; 56: 784-794
  • 23 Schachman HK, Edelstein SJ. Ultracentrifuge studies with absorption optics. IV. Molecular weight determinations at the microgram level. Biochemistry 1966; 5: 2681-2688
  • 24 Svedberg T, Pedersen KO. The Ultracentrifuge. Johnson Reprint Corp. New York: 1959
  • 25 Mann KG, Nesheim ME, Tracy PB. Molecular weight of undegraded plasma factor V. Biochemistry 1981; 20: 28-33